Paige appoints new executives

By LabPulse.com staff writers

January 12, 2022 -- Artificial intelligence (AI) software developer Paige announced that it has appointed new executive leaders, including Andy Moye, PhD, as CEO and Jill Stefanelli, PhD, as president and chief business officer.

Moye most recently served as Paige's chief commercial officer, leading the company's clinical sales and commercial strategy, including the U.S. launch of the AI-based Paige Prostate.

Stefanelli served most recently as Paige's chief precision medicine officer, leading the company's strategic partnerships with life science companies and biomarker development strategy.

Paige AI software gets U.K. medtech innovation evaluation
The U.K.'s National Institute for Health and Care Excellence (NICE) has published a Medtech Innovation Briefing (MIB) on Paige's Paige Prostate artificial...
FDA clears 1st prostate pathology AI software application
The U.S. Food and Drug Administration (FDA) has authorized marketing of Paige.ai's Paige Prostate artificial intelligence (AI) software, the first prostate...
Perspectum and Paige partner up to improve workflow in trials
Image analysis software developer Perspectum and digital pathology company Paige announced a strategic partnership to leverage quantitative and artificial...
Quest, Paige to collaborate on AI software for pathology
Quest Diagnostics and Paige plan to collaborate on developing new software that will incorporate artificial intelligence (AI) and digital pathology data...
Inform works with Paige on digital pathology workflow
Anatomic pathology provider Inform Diagnostics announced it will work with artificial intelligence software developer Paige to implement digital pathology...

Copyright © 2022 LabPulse.com

Last Updated ls 1/12/2022 2:42:19 PM